Entering text into the input field will update the search result below

Abcam gains on report it's seeing takeover interest from Danaher, Agilent

Jun. 30, 2023 11:57 AM ETAbcam plc (ABCM)DHR, A, MKGAFBy: Joshua Fineman, SA News Editor
Team of Research Scientists Working On Computer, with Medical Equipment, Analyzing Blood and Genetic Material Samples with Special Machines in the Modern Laboratory.

gorodenkoff/iStock via Getty Images

Abcam (NASDAQ:ABCM) ADRs rose 4% on a report that the biotechnology supplier is seeing initial interest from Danaher (DHR) and Agilent Technologies (A).

Abcam (ABCM) has also separately reached out to other companies, including Germany's Merck KGaA (OTCPK:MKGAF

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About ABCM

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Abcam plc
CRISPR Therapeutics AG
BridgeBio Pharma, Inc.
Halozyme Therapeutics, Inc.
Immunovant, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.